User talk:Gambit21

Your submission at Articles for creation: Exponential Technologies has been accepted
 Exponential Technologies, which you submitted to Articles for creation, has been created.

Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions.

The article has been assessed as Stub-Class, which is recorded on its talk page. It is commonplace for new articles to start out as stubs and then attain higher grades as they develop over time. You may like to take a look at the grading scheme to see how you can improve the article.

Since you have made at least 10 edits over more than four days, you can now create articles yourself without posting a request. However, you may continue submitting work to Articles for creation if you prefer.

If you have any questions, you are welcome to ask at the  [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk&action=edit&section=new&nosummary=1&preload=Template:AfC_talk/HD_preload&preloadparams%5B%5D=Exponential_Technologies help desk] . Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.

If you would like to help us improve this process, please consider.

Thanks again, and happy editing! Nathan2055talk - contribs 00:21, 22 December 2020 (UTC)

December 2020
Hello, and welcome to Wikipedia! Thank you for your contributions; however, please remember the essential rule of respecting copyrights. Edits to Wikipedia, such as your edit to the page Ultratrace element, may not contain material from copyrighted sources unless used with permission. It is almost never okay to copy extensive text out of a book or website and paste it into a Wikipedia article with little or no alteration, though you can clearly and briefly quote copyrighted text in the right circumstances. Content that does not comply with this legal rule must be removed. For more information on this, see:
 * Copying text from other sources
 * Policy on copyright
 * Frequently asked questions on Wikipedia's copyright policy
 * Policy and guideline on non-free content

If you still have questions, there is the teahouse, or you can and someone will be along to answer it shortly. As you get started, you may find the pages below to be helpful.


 * Introduction
 * Contributing to Wikipedia
 * The five pillars of Wikipedia
 * How to edit a page
 * How to create your first article
 * Simplified Manual of Style

I hope you enjoy editing Wikipedia! Please sign your name on talk pages using four tildes ( ~ ); this will automatically produce your name and the date. Feel free to write a note on the bottom of my talk page if you want to get in touch with me. Again, welcome! — Diannaa (talk) 22:21, 22 December 2020 (UTC)

Deletion discussion about HIF strengthening factor
Hello, Gambit21, and welcome to Wikipedia. I edit here too, under the username Graeme Bartlett, and I thank you for your contributions.

I wanted to let you know, however, that I've started a discussion about whether an article that you created, HIF strengthening factor, should be deleted, as I am not sure that it is suitable for inclusion in Wikipedia in its current form. Your comments are welcome at Articles for deletion/HIF strengthening factor.

You might like to note that such discussions usually run for seven days and are not ballot-polls. And, our guide about effectively contributing to such discussions is worth a read. Last but not least, you are highly encouraged to continue improving the article; just be sure not to remove the tag about the deletion nomination from the top.

If you have any questions, please leave a comment here and prepend it with. And, don't forget to sign your reply with. Thanks!

(Message delivered via the Page Curation tool, on behalf of the reviewer.)

Graeme Bartlett (talk) 23:32, 25 December 2020 (UTC)

Dear (talk),

I have commented on the deletion discussion illustrating wh I think a lone standing article on HIF strengthening molecules has merit. I am looking forward to your reply.

Best

Gambit21 (talk) 09:03, 26 December 2020 (UTC)
 * Actually I failed to nominate this for deletion properly, so I changed my mind about the AFD and just changed it to a redirect. As the content would be better merged. However I see that you created the Articles for deletion/HIF strengthening factor. I don't think it will result in anything happening as I did not end up with my reason for deletion being added. Graeme Bartlett (talk) 12:12, 26 December 2020 (UTC)

Dear @Graeme Bartlett:.

Ah, thank you, I am unfamiliar with this protocol. However I think the redirect or any merger with existing articles (I looked at Deferoxamine, Deferiprone, Minoxidil, Chelation therapy and some more) would be misleading and loose important information (see my reasons below) and a lone standing article is best. Can you please cancel your redirect?

I think redirect is not correct because:

1. HIF strengthening factor is a molecule not limited to the example of Deferoxamine. In fact it is at least also Deferiprone used and called HSF in the scientific literature. See this paper for example where this is the case (HSF as a term is mentioned in the manuscript 3 times): https://pubmed.ncbi.nlm.nih.gov/32479616/ also Sodium Gluconate, Minoxidil and DMOG have been used in this context (meaning HIF strengthening/stabilisation for regeneration). I can't see how this could fit all under Deferoxamine. It would be short of important aspects. I also checked out the other molecule articles and the chelation therapy article for a potential merger. However, the HIF strengthening effect is via inhomogenious mechanistics (one time via pro chelation, another time via PHD inhibition) and therefore does't fit in either of the other articles as a subheading or so. This further confirmed my belief that this should be kept as a stand alone article.

2. The article gives insights on the very important regenerative aspects of HIF stimulation. HIF stimulation as an aspect of Deferoxamine is not covered in the Deferoxamine article let alone the implications of it for regneration.

In conclusion I think my article on the new molecule type HSF that stimulates HIF signaling for regenerative purposes (wound healing, scar mitigation, skin and hair regeneration) has merit, adds important information and should be kept as a lone standing article.

Best greetings

Gambit21 (talk) 11:10, 26 December 2020 (UTC)
 * I have now properly nominated the page, so we should get input from other people. Graeme Bartlett (talk) 01:34, 28 December 2020 (UTC)